Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites.
Chen D, Wang Y, Yang J, Ou W, Lin G, Zeng Z, Lu X, Chen Z, Zou L, Tian Y, Wu A, Keating SE, Yang Q, Lin C, Liang Y.
Chen D, et al. Among authors: liang y.
Front Pharmacol. 2024 Apr 24;15:1343755. doi: 10.3389/fphar.2024.1343755. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38720776
Free PMC article.